Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant-Reference-Cited by-同舟云学术

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

Published:2021-06 Issue:6 Volume:54 Page:1276-1289.e6
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Graham Carl,Seow Jeffrey^ORCID,Huettner Isabella,Khan Hataf^ORCID,Kouphou Neophytos^ORCID,Acors Sam^ORCID,Winstone Helena,Pickering Suzanne,Galao Rui Pedro,Dupont Liane^ORCID,Lista Maria Jose,Jimenez-Guardeño Jose M.,Laing Adam G.,Wu Yin^ORCID,Joseph Magdalene^ORCID,Muir Luke^ORCID,van Gils Marit J.,Ng Weng M.^ORCID,Duyvesteyn Helen M.E.^ORCID,Zhao Yuguang^ORCID,Bowden Thomas A.^ORCID,Shankar-Hari Manu^ORCID,Rosa Annachiara^ORCID,Cherepanov Peter,McCoy Laura E.,Hayday Adrian C.,Neil Stuart J.D.^ORCID,Malim Michael H.,Doores Katie J.

Funder

NIAID

NIHR

Medical Research Council

Wellcome Trust

European Commission

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference86 articles.

1. SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma;Andreano;bioRxiv,2020